Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Reader Login
  Users Online: 1004Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2011| October-December  | Volume 2 | Issue 4  
    Online since October 31, 2011

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
RESEARCH METHODOLOGY
Patient-reported outcomes: A new era in clinical research
Prasanna R Deshpande, Surulivel Rajan, B Lakshmi Sudeepthi, CP Abdul Nazir
October-December 2011, 2(4):137-144
DOI:10.4103/2229-3485.86879  
  219 11,026 2,533
STATISTICS
Survival analysis in clinical trials: Basics and must know areas
Ritesh Singh, Keshab Mukhopadhyay
October-December 2011, 2(4):145-148
DOI:10.4103/2229-3485.86872  
  36 12,781 2,508
ORIGINAL ARTICLE
An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital
Chetna K Desai, Geetha Iyer, Jigar Panchal, Samidh Shah, RK Dikshit
October-December 2011, 2(4):129-136
DOI:10.4103/2229-3485.86883  
  19 5,976 1,375
QUALITY
Quality of clinical trials: A moving target
Arun Bhatt
October-December 2011, 2(4):124-128
DOI:10.4103/2229-3485.86880  
  15 5,609 1,370
EDITORIAL
Non-inferiority and equivalence trials: Need for a standardized process
Suresh Keshav Bowalekar
October-December 2011, 2(4):115-118
DOI:10.4103/2229-3485.86868  
  2 3,075 5,565
LETTER TO EDITOR
Plagiarism: Pre-submission screening
Viroj Wiwanitkit
October-December 2011, 2(4):149-150
DOI:10.4103/2229-3485.86869  
  2 1,635 393
REGULATORY
Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
Sandeep Kumar Gupta
October-December 2011, 2(4):121-123
DOI:10.4103/2229-3485.86874  
  2 2,849 1,198
LETTER TO EDITOR
Documents versus facts
Rakesh Parikh
October-December 2011, 2(4):149-149
DOI:10.4103/2229-3485.86867  
  - 2,022 253
OPINION
Industry commitment to the science of safety
Viraj Suvarna
October-December 2011, 2(4):119-120
DOI:10.4103/2229-3485.86870  
  - 2,197 1,908
  Feedback 
  Subscribe